Annovis Bio Receives NYSE Noncompliance Notice Over Listing Shortfalls
Photo: TokenPost
Annovis Bio, Inc. (NYSE: ANVS) received a noncompliance notice from the New York Stock Exchange on Oct. 29 after falling short of continued-listing standards for market capitalization and stockholders’ equity. The company’s average market capitalization over 30 trading days was about $48.4 million as of Oct. 28. Its stockholders’ deficit was about $4.3 million as of June 30. Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
